Eurofins Scientific SE ERFSF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $63.43
- Day Range
- $62.34–67.06
- 52-Week Range
- $47.14–72.39
- Bid/Ask
- $62.34 / $67.33
- Market Cap
- $12.03 Bil
- Volume/Avg
- 1,039 / 1,623
Key Statistics
- Price/Earnings (Normalized)
- 20.81
- Price/Sales
- 1.82
- Dividend Yield (Trailing)
- 1.67%
- Dividend Yield (Forward)
- 1.81%
- Total Yield
- 2.08%
Company Profile
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its areas of business activity are food, feed, and environmental testing ("Life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Core
- Total Number of Employees
- 61,798
- Website
- https://www.eurofins.com
Competitors
Valuation
|
Metric
|
ERFSF
|
BVI
|
ITRK
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.81 | 19.24 | 20.97 |
Price/Book Value | 2.77 | 6.29 | 5.91 |
Price/Sales | 1.82 | 2.09 | 2.37 |
Price/Cash Flow | 11.75 | 14.35 | 14.99 |
Price/Earnings
ERFSF
BVI
ITRK
Financial Strength
|
Metric
|
ERFSF
|
BVI
|
ITRK
|
|---|---|---|---|
Quick Ratio | 1.34 | 1.64 | 1.02 |
Current Ratio | 1.45 | 1.67 | 1.09 |
Interest Coverage | 4.18 | 8.40 | 10.40 |
Quick Ratio
ERFSF
BVI
ITRK
Profitability
|
Metric
|
ERFSF
|
BVI
|
ITRK
|
|---|---|---|---|
Return on Assets (Normalized) | 5.44% | 8.25% | 10.16% |
Return on Equity (Normalized) | 13.87% | 31.39% | 28.28% |
Return on Invested Capital (Normalized) | 7.66% | 12.79% | 14.92% |
Return on Assets
ERFSF
BVI
ITRK
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Vzyjgvghfb | Gdxcp | $212.9 Bil | |
DHR
| Danaher Corp | Sczchpjd | Kprqm | $177.5 Bil | |
IQV
| IQVIA Holdings Inc | Mvrgpjyv | Yjtbf | $42.6 Bil | |
A
| Agilent Technologies Inc | Rqtktgdmg | Dzwvf | $41.1 Bil | |
IDXX
| IDEXX Laboratories Inc | Tltwngwbss | Sqhyyxl | $40.8 Bil | |
MTD
| Mettler-Toledo International Inc | Nydmppcnd | Gclxrz | $26.6 Bil | |
ICLR
| Icon PLC | Ptpkbhvt | Mysym | $24.7 Bil | |
ILMN
| Illumina Inc | Hvpntjx | Smznzl | $19.3 Bil | |
WAT
| Waters Corp | Ltbnhmqw | Vrbrs | $19.0 Bil | |
LH
| Laboratory Corp of America Holdings | Bpdndpjpz | Tpytpw | $17.1 Bil |